Literature DB >> 27558082

Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.

Kah-Lok Chan1, Carrie van der Weyden1, Christine Khoo2, Stephen Lade2, Piers Blombery1, David Westerman1,3, Amit Khot1, Brian Melo4, Ricky W Johnstone3,5, H Miles Prince1,3, Michael Dickinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27558082     DOI： 10.1080/10428194.2016.1222375

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  Intradural extramedullary relapse of peripheral T-cell lymphoma, NOS.

Authors:  Yutaka Shimazu; Akihiko Sakata; Masaharu Nohgawa
Journal:  J Clin Exp Hematop       Date:  2020

Review 2.  Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.

Authors:  Ping Zhang; Mingzhi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-07       Impact factor: 6.551
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.